Alicia Palladino > Goodwin > Philadelphia, United States > Lawyer Profile
Goodwin Offices
One Commerce Square
2005 Market St, 32nd floor
Philadelphia, Pennsylvania
19103
United States
- Firm Profile
- Go to...
Alicia Palladino
Position
Partner
Career
Alicia Palladino is a partner at Goodwin. With a PhD in biomedical science, Alicia uses her experience to prosecute patents in the US and all over the globe, specifically in areas such as pharmaceutical sciences, nutraceuticals, biologics, dermatological compositions, and cosmetics.
Alicia’s focus includes working with companies to increase the value of their assets by advising her clients of matters regarding regulatory data, marketing exclusivity, and trade secrets. She also advises her clients on eligible patent term extensions and patent listings. In addition, she prepares and files patent applications, and secures patents for pharmaceuticals, diagnostics, and biologics for a myriad of different products such as formulations, chemical coatings, polymers, delivery systems, extended-release systems, biologics, and more.
As an IP attorney, Alicia advises companies on IP strategy, and counsels clients on internal IP due diligence. This can include conducting reviews and audits on behalf of pharmaceutical, bio pharmaceutical, and medical device companies in preparation for partnering, financing, and public offerings. She also provides counsel on preparing non-disclosure agreements, consulting agreements, license agreements, and collaboration and joint venture agreements for chemical and life sciences companies.
Education
JD 2015 University of Pittsburgh School of Law; PhD 2002 UConn Health; BS 1995 University of Saint Joseph (with honors)
Top Tier Firm Rankings
- Finance > Financial services regulation
- Industry focus > Cannabis
- Intellectual property > Patents: licensing
- M&A/corporate and commercial > Private equity buyouts: middle-market (Up to $500m)
- Real estate > Real estate investment trusts (REITs)
- Media, technology and telecoms > Technology transactions
- M&A/corporate and commercial > Venture capital and emerging companies
Firm Rankings
- Finance > Capital markets: equity offerings
- Labor and employment > ERISA litigation
- Finance > Fintech
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- M&A/corporate and commercial > M&A: middle-market ($500m-999m)
- Real estate > Real estate
- Dispute resolution > Securities litigation: defense
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Finance > Capital markets: debt offerings
- International trade > CFIUS
- M&A/corporate and commercial > Corporate governance
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Dispute resolution > E-discovery
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Dispute resolution > Financial services litigation
- Antitrust > Merger control
- Intellectual property > Patents: litigation (full coverage)
- Investment fund formation and management > Private equity funds (including venture capital)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Tax > US taxes: non-contentious
- Labor and employment > Workplace and employment counseling
- International trade > Customs, export controls and economic sanctions
- Healthcare > Service providers
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Leading trial lawyers
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Commercial lending
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Intellectual property > Patents: litigation (International Trade Commission)
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- M&A/corporate and commercial > Shareholder activism